Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00486265
Status:
TERMINATED
Last Update Posted:
2010-12-21
First Post:
2007-06-13
Brief Title:
Phase III Open-label Multi-center Two Part Dose-escalation Safety Pharmacokinetics PK and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia AML
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-13
First Submit QC Date:
June 13 2007
Study First Post Date:
2007-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-08-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-12-07
Last Update Post Date:
2010-12-21
Last Update Post Date Type:
ESTIMATED